News & Articles

Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events

Harnessing the most powerful force in the fight against disease — natural human immunity

The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford

First patients are expected to be enrolled shortly and additional European regulatory approvals are in process

The result represents an essential step towards using these molecules for fundamental physics research and beyond

The platform aims to help researchers generate a clearer view of the current state of research and gain invaluable insights

People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus

Microsemi CRP hematology analyzers have been installed during COVID-19 ‘lockdown’ in POC locations to help reduce hospital admissions

Discover how clinicians at the Center for Personalized Medicine identify and track different coronavirus strains

Register for this webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine

Join this expert webinar on Wednesday, June 10, to learn how to improve throughput and result quality in PCR and qPCR workflows

Cambridge Cognition has secured over $1.5 million in new contracts to support pharmaceutical clients in delivering virtual clinical trials

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

COVID-19 molecular diagnostic and serology antibody testing at core of new suite of services

Ms. Knauer received a certificate signed by the German Federal Minister of Economics and Energy Peter Altmaier

The CE-IVD marked system will enable diagnostic pathologists with new applications

Download this white paper from Sartorius to discover how enhanced data analytics and translational models can provide new biological insights

As a cryogenic supplier, Air Products looks at both modes of sample storage and compares them in terms of accessibility, reliability and temperature

The company aims to ramp up its production capacity of more than 50 million antibody tests per month